NovaSterilis Announces EMCM as Strategic Partner for Supercritical CO2 Sterilisation in Europe and Parts of Asia

November 13, 2012

NovaSterilis Inc., a leader in the development and commercialisation of supercritical carbon dioxide (scCO2) technology announces the addition of European Medical Contract Manufacturing (EMCM) as a licensee of supercritical CO2 sterilisation and NovaSterilis’ exclusive agent for supercritical CO2 technology and equipment in specified territories.